Here is a breakdown of six recalls reported by Becker’s Hospital Review or published by the FDA in the last two weeks.
1. Recalled drugs: Levothyroxine and Liothyronine
Reason for recall: Risk of adulteration. The drugs were manufactured using ingredients from a Chinese drugmaker that had deficiencies in its manufacturing practices
Date of recall: Aug. 9
Drugmaker: Westminster Pharmaceuticals
2. Recalled drug: Valsartan tablets
Reason for recall: Detection of probable human carcinogen, n-nitrosodimethylamine
Date of recall: Aug. 8
Drugmaker: Camber Pharmaceuticals
3. Recalled drug: CVS Health 12-Hour Sinus Relief nasal mist
Reason for recall: Product contaminated with bacteria, identified as Pseudomonas aeruginosa
Date of recall: Aug. 8
Drugmaker: Product Quest Manufacturing
4. Recalled drug: Testosterone Cypionate injections
Reason for recall: Presence of particulate matter in the vials
Date of recall: Aug. 5
Drugmaker: Sun Pharmaceutical Industries
5. Recalled drugs: Piperacillin and Tazobactum
Reason for recall: Product complaints uncovered glass and silicone particles in vials
Date of recall: July 31
Drugmaker: AuroMedics Pharma
6. Recalled drugs: All sterile compounded drugs
Reason for recall: Concerns over potential contamination of sterile products
Date of recall: July 28
Drugmaker: Ranier’s Rx Laboratory
More articles on pharmacy:
Pharmacy middlemen not to blame for high drug prices, CVS chief says
FDA generic drug approvals hit record high in July
Mylan’s Q2 revenue down 5%; US healthcare changes cited
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.